Penn Interventional Psychiatry Network
Penn Interventional Psychiatry Network offers esketamine treatment in Philadelphia, Pennsylvania for adults whose depression has not responded to adequate medication trials. Esketamine is a nasal spray approved by the FDA, sold under the brand name Spravato, and is used alongside other antidepressants.
Care starts with an evaluation by a psychiatrist who specializes in mood disorders. That visit screens for health conditions that would make the treatment unsafe. Scheduling depends on insurance approval.
Doses are given twice a week for up to four weeks, and every patient is watched for at least two hours afterward. Driving is not allowed after treatment. If symptoms improve, doses can shift to a maintenance schedule of once a week to once a month.
The program also offers TMS, ECT, and brain stimulation implants. It serves Philadelphia and the surrounding region.
Clinic-wide information; ask which treatments are appropriate for you.
Accepts insurance
Plan participation and treatment coverage may vary by location and clinician. Confirm your benefits with the clinic.
The Penn Interventional Psychiatry Network clinical service at the University of Pennsylvania is now accepting Medicare, Aetna, Humana Military, and Penn Behavioral Health insurance plans. Blue Shield plans may also be accepted depending on plan benefits.
Contact clinic for pricing.
Send your details to Penn Interventional Psychiatry Network and they can reach out to you directly.
Is this your clinic?
Get a featured listing to appear at the top of search results and attract more patients.
Get Featured